Cxcr6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Taghizadeh, Rouzbeh ^a   Noh, Minsoo ^b   Huh, Yang Hoon ^a   Ciusani, Emilio ^c   Sigalotti, Luca ^d   Maio, Michele ^d   Arosio, Beatrice ^e   Nicotra, Maria R ^f   Natali, Piergiorgio ^g   Sherley, James L ^a   la Porta, Caterina A M ^e  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b Ajou University   (South Korea)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f CNR   (Italy)

^g UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CHEMOKINE RECEPTOR CXCR6; MELANOMA ANTIGEN; TUMOR MARKER; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR; CXCR6 PROTEIN, HUMAN; CXCR6 PROTEIN, MOUSE; TUMOR PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CELL CULTURE; CELL FUNCTION; CELL RENEWAL; CELL SUBPOPULATION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; TISSUE SPECIFICITY; ANIMAL; CANCER INVASION; CANCER TRANSPLANTATION; CYTOLOGY; METABOLISM; METASTASIS; METHODOLOGY; MOLECULAR BIOLOGY; MUTATION; SKIN TUMOR; TUMOR CELL LINE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; HUMANS; MELANOMA; MICE; MOLECULAR BIOLOGY; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR; RECEPTORS, VIRUS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650966288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015183     Document Type: Article

References (30)

1. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters Nat Rev Cancer 2: 48-58.
2. La Porta CAM (2010) Mechanism of Drug Sensitivity and Resistance in Melanoma Current Cancer Drug Targets 9: 391-397.
3. Tamura A, Watanabe M, Saito H, Nakagawa H, Kamachi T, et al. (2006) Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. Molecular pharmacology 70: 287-296.
4. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, et al. (2007) Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential. Eur J Cancer 43: 935-946.
5. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, et al. (2008) Identification of cells initiating human melanomas. Nature 451: 345-349.
6. La Porta CAM (2009) Cancer Stem cells: a lesson from melanoma. Stem Cell Reviews and Rep 5: 61-65.
7. Loeffler M, Potten CS (1997) Stem cells and cellular pedigrees- a conceptual introduction. In Stem Cells Potten CS, ed. San Diego, CA: Harcourt Brace & Co. pp 1-28.
8. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 Nature 466: 133-137.
9. Sherley JL (2005) Asymmetric Self-Renewal: The Mark of the Adult Stem Cell in Stem Cell Repair and Regeneration, eds. Habib NA, Gordon MY, Levicar N, Jiao L, Thomas-Black G, eds. Imperial College Press (London). pp 21-28.
10. Deng H, Unutmaz D, Kewalramani VN, Littman DR (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997; 388: 296-300.
11. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, et al. (2001) Bonzo/ CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 107: 595-601.
12. Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, et al. (2008) The Chemokine Receptor CXCR6 and Its Ligand CXCL16 are expressed in Carcinomas and Inhibit Proliferation. Cancer Res 68: 4701-4708.
13. Seidl H, Richtig E, Tilz H, Stefan M, Schmidbauer U, et al. (2007) Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum Pathol 38: 768-80.
14. Hannes B, Richtig E, Tilz H, Stefan M, Schmidbauer U, et al. (2007) Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma Human Pathology 38: 768-780.
15. Rambhatla L, Bohn SA, Stadler PB, Boyd JT, Coss RA, et al. (2001) Cellular Senescence: Ex vivo p53-Dependent Asymmetric Cell Kinetics. J Biomed Biotech 1: 27-36.
16. Liu Y, Bohn SA, Sherley JL (1998a) Inosine-5'-Monophosphate Dehydrogenase is a Rate-Determining Factor for p53-Dependent Growth Regulation Molecular Biology of the Cell 9: 15-28.
17. Liu Y, Riley LB, Bohn SA (1998b) Comparison of Bax, Waf1, and IMP Dehydrogenase Regulation in Response to Wild-type p53 Expression Under Normal Growth Conditions J Cellular Physiology 177: 364-376.
18. Rambhatla L, Ram-Mohan S, Cheng JJ, Sherley JL (2005) Immortal DNA Strand Co-Segregation Requires p53/IMPDH-Dependent Asymmetric Self- Renewal Associated with Adult Stem Cells Cancer Research 65: 3155-3161.
19. Lee HS, Crane GG, Merok JR, Tunstead JR, Hatch NL, et al. (2003) Clonal expansion of adult rat liver epithelial stem cells by suppression of asymmetric cell kinetics (SACK) Biotech & Bioeng 83: 760-771.
20. Merok JR, Lansita JA, Tunstead JR, Sherley JL (2002) Co-segregation of Chromosomes Containing Immortal DNA Strands in Cells That Cycle With Asymmetric Stem Cell Kinetics, Cancer Research 62: 6791-6795.
21. Darzynkiewicz Z, Gong J, Ardelt B, Ardelt B, Traganos F (1996) Cytometry of Cyclin Proteins Cytometry 25: 1-13.
22. Zamber CP, Lamba JK, Yasuda K, Farnum J, Thummel K, et al. (2003) Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 13: 19-28.
23. Kondo C, Suzuki H, Itoda M, Ozawa S, Sawada J, et al. (2004) Functional analysis of SNPs variants of BCRP/ABCG2. Pharmaceutical Research 21: 1895-190.
24. Tamura A, Watanabe M, Saito H, Nakagawa H, Tsuji M, et al. (2006) Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. Mol Pharmacol 70: 287-96.
25. Nakagawa H, Tamura A, Wakabayashi K, Hoshijima K, Komada M, et al. (2008) Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. The Biochemical Journal 411: 623-631.
26. Jager E, Rainhoffer M, Altmannsberger M, Arand M, Karbach J, et al. (1997) Immunoseletion in vivo, independent loss of MHI class I and melanocyte differentiatiuon antigen expression in metastatic melanomas;Int J Cancer 71: 142-147.
27. Sigalotti L, Coral S, Altomonte M, Natali L, Gaudino G, et al. (2002) Cancer testis antigens expression inmesotheliom: role of DNA methylation and bioimmunotherapeutic implication. Br J Cancer 18: 979-982.
28. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
29. Coral S, Sigalotti L, Gasparollo A, Cattarossi I, Visintin A, et al. (1999) Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR). J Immunother 22: 16-24.
30. Calabro L, Fonsatti E, Altomonte M, Pezzani L, Colizzi F, et al. (2005) Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications. J Cell Physiol 202: 474-477.